Sanuwave Health, INC Form 4 insider transactions

Sanuwave Health provides an update on its merger with SEPA, including a change in listing exchange application, settlement of a $6.3 million debt for $2.075 million, and reaffirmation of its financial guidance for 2024.

SANUWAVE Health and SEP Acquisition Corp. amend their merger agreement, extending the outside date to June 30, 2024, and granting SANUWAVE a unilateral termination right.

Manchester Management converted a Future Advance Convertible Promissory Note into 8,625,000 shares of Sanuwave Health, Inc. common stock at $0.04 per share.

SANUWAVE Health, Inc. and SEP Acquisition Corp. have amended their merger agreement to extend the outside date for completing the transaction to May 31, 2024.

SANUWAVE Health and SEP Acquisition Corp. have amended their merger agreement to extend the outside date for completing the business combination to April 30, 2024.